PP
AGTC

PDT Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

PDT Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18,600
Closed -$136K – 527
2018
Q3 		$136K Buy
18,600
+2,100
+13% +$9.2K 0.01% 448
2018
Q2 		$61K Hold
16,500
– – ﹤0.01% 501
2018
Q1 		$64K Buy
16,500
+5,300
+47% +$22.3K ﹤0.01% 549
2017
Q4 		$40K Sell
11,200
-5,881
-34% -$22.2K ﹤0.01% 528
2017
Q3 		$67K Sell
17,081
-16,019
-48% -$73.6K ﹤0.01% 510
2017
Q2 		$169K Hold
33,100
– – 0.01% 493
2017
Q1 		$228K Buy
33,100
+10,200
+45% +$79.7K 0.01% 437
2016
Q4 		$214K Buy
22,900
+4,700
+26% +$42.3K 0.01% 461
2016
Q3 		$178K Buy
+18,200
New +$245K 0.01% 443

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

PDT Partners's AGTC Position: Q4 2018 in Review

PDT Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2018, closing a stake of 18,600 shares — an estimated $136K sold.

PDT Partners first reported a position in AGTC in Q3 2016 and held it in 9 quarters. The position peaked at $228K in Q1 2017. 54 funds tracked by Wall St. Rank hold AGTC as of Q4 2018.

  • PDT Partners reported no remaining Applied Genetic Technologies Corporation position as of Q4 2018 after selling out during the quarter.
  • PDT Partners sold 18,600 Applied Genetic Technologies Corporation shares in Q4 2018, an estimated $136K.
  • PDT Partners first reported a position in Applied Genetic Technologies Corporation in Q3 2016 and held it in 9 quarters.
  • PDT Partners's Applied Genetic Technologies Corporation position peaked at $228K in Q1 2017.
  • 54 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2018.

Based on PDT Partners's 13F filing for Q4 2018, filed 14 Feb 2019.